Suppr超能文献

P2Y(1)和P2Y(12)受体介导交感神经支配组织中递质释放的自身抑制。

The P2Y(1) and P2Y(12) receptors mediate autoinhibition of transmitter release in sympathetic innervated tissues.

作者信息

Quintas Clara, Fraga Sónia, Gonçalves Jorge, Queiroz Glória

机构信息

REQUIMTE, University of Porto, Portugal.

出版信息

Neurochem Int. 2009 Dec;55(7):505-13. doi: 10.1016/j.neuint.2009.05.002. Epub 2009 May 15.

Abstract

In the sympathetic nervous system, ATP is a co-transmitter and modulator of transmitter release, inhibiting noradrenaline release by acting on P2Y autoreceptors, but in peripheral tissues the subtypes involved have only scarcely been identified. We investigated the identity of the noradrenaline release-inhibiting P2Y subtypes in the epididymal portion of vas deferens and tail artery of the rat. The subtypes operating as autoreceptors, the signalling mechanism and cross-talk with alpha(2)-autoreceptors, was also investigated in the epididymal portion. In both tissues, the nucleotides 2-methylthioATP, 2-methylthioADP, ADP and ATP inhibited noradrenaline release up to 68%, with the following order of potency: 2-methylthioADP=2-methylthioATP>ADP=ATP in the epididymal portion and 2-methylthioADP=2-methylthioATP=ADP>ATP in the tail artery. The selective P2Y(1) antagonist 2'-deoxy-N(6)-methyladenosine 3',5'-bisphosphate (30microM) and the P2Y(12) antagonist 2,2-dimethyl-propionic acid 3-(2-chloro-6-methylaminopurin-9-yl)-2-(2,2-dimethyl-propionyloxymethyl)-propyl ester (30microM) increased noradrenaline release per se by 25+/-8% and 18+/-3%, respectively, in the epididymal portion but not in tail artery. Both antagonists attenuated the effect of nucleotides in the epididymal portion whereas in tail artery only the P2Y(1) antagonist was effective. The agonist of P2Y(1) and P2Y(12) receptors, 2-methylthioADP, caused an inhibition of noradrenaline release that was not prevented by inhibition of phospholipase C or protein kinase C but was abolished by pertussis toxin. 2-methylthioADP and the adenosine A(1) receptor agonist N(6)-cyclopentyladenosine were less potent at inhibiting noradrenaline release under marked influence of alpha(2)-autoinhibition. In both tissues, nucleotides modulate noradrenaline release by activation of inhibitory P2Y(1) receptors but in the epididymal portion P2Y(12) receptors also participate. P2Y(1) and P2Y(12) receptors are coupled to G(i/o)-proteins and operate as autoreceptors in the vas deferens where they interact with alpha(2)-adrenoceptors on the modulation of noradrenaline release.

摘要

在交感神经系统中,ATP是一种共递质和递质释放的调节剂,通过作用于P2Y自身受体抑制去甲肾上腺素的释放,但在外周组织中,所涉及的亚型几乎未被鉴定出来。我们研究了大鼠输精管附睾段和尾动脉中抑制去甲肾上腺素释放的P2Y亚型的特性。还在附睾段研究了作为自身受体起作用的亚型、信号传导机制以及与α₂自身受体的相互作用。在这两种组织中,核苷酸2-甲硫基ATP、2-甲硫基ADP、ADP和ATP可抑制高达68%的去甲肾上腺素释放,其效力顺序如下:在附睾段为2-甲硫基ADP = 2-甲硫基ATP>ADP = ATP,在尾动脉为2-甲硫基ADP = 2-甲硫基ATP = ADP>ATP。选择性P2Y₁拮抗剂2'-脱氧-N⁶-甲基腺苷3',5'-双磷酸酯(30μM)和P2Y₁₂拮抗剂2,2-二甲基丙酸3-(2-氯-6-甲基氨基嘌呤-9-基)-2-(2,2-二甲基丙酰氧基甲基)-丙酯(30μM)本身在附睾段可使去甲肾上腺素释放分别增加25±8%和18±3%,但在尾动脉中无此作用。两种拮抗剂均减弱了附睾段中核苷酸的作用,而在尾动脉中只有P2Y₁拮抗剂有效。P2Y₁和P2Y₁₂受体的激动剂2-甲硫基ADP可抑制去甲肾上腺素释放,这种抑制作用不受磷脂酶C或蛋白激酶C抑制的影响,但可被百日咳毒素消除。在α₂自身抑制的显著影响下,2-甲硫基ADP和腺苷A₁受体激动剂N⁶-环戊基腺苷抑制去甲肾上腺素释放的效力较低。在这两种组织中,核苷酸通过激活抑制性P2Y₁受体调节去甲肾上腺素释放,但在附睾段P2Y₁₂受体也参与其中。P2Y₁和P2Y₁₂受体与G(i/o)蛋白偶联,在输精管中作为自身受体发挥作用,在去甲肾上腺素释放的调节过程中它们与α₂肾上腺素能受体相互作用。

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验